Kirkland & Ellis advised Ingersoll Rand Inc. on the transaction, and Simpson Thacher & Bartlett advised ILC Dover and New Mountain Capital. Ingersoll Rand Inc. (NYSE:IR),...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction. Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330...
You must be a Standard 1 Year member to access this content.
Fried, Frank, Harris, Shriver & Jacobson LLP advised Blue Owl, while Simpson Thacher & Bartlett LLP advised Stonepeak in the deal. Blue Owl’s GP Strategic Capital...
You must be a Standard 1 Year member to access this content.
